Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 9, 2013 - Issue
Submit an article Journal homepage
97
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Clinically significant interactions between antiretroviral and co-prescribed drugs for HIV-infected children: profiling and comparison of two drug databases

Kazeem A Oshikoya1 Department of Pharmacology, Lagos State University College of Medicine, Ikeja, Lagos, NigeriaCorrespondence[email protected]
,
Ibrahim A Oreagba2 Department of Pharmacology, College of Medicine, University of Lagos, Idi Araba, Lagos, Nigeria
,
Olayinka O Ogunleye1 Department of Pharmacology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria
,
Saheed Lawal2 Department of Pharmacology, College of Medicine, University of Lagos, Idi Araba, Lagos, Nigeria
&
Idowu O Senbanjo3 Department of Paediatric and Child Health, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria
Pages 215-221 | Published online: 14 May 2013

References

  • Evans-JonesJGCottleLEBackDJRecognition of risk for clinically significant drug interactions among HIV-infected patients receiving antiretroviral therapyClin Infect Dis201050101419142120380564
  • KigenGKimaiyoSNyandikoWPrevalence of potential drug– drug interactions involving antiretroviral drugs in a large Kenyan cohortPLoS ONE201162e1680021373194
  • World Health OrganizationAntiretroviral Therapy of HIV Infection in Infants and Children: Towards Universal AccessGenevaWorld Health Organization2006 Available from: http://www.who.int/hiv/pub/guidelines/paediatric020907.pdfAccessed October 22, 2011
  • JordanRGoldLCumminsCHydeCSystematic review of metaanalysis of evidence for increasing numbers of drugs in antiretroviral combination therapyBMJ2002324734075711923157
  • MICROMEDEX®Gateway [database on the Internet]Greenwood Village, CO, USAThomson Reuters2013 Available from: http://www.thomsonhc.com/homeAccessed February 12, 2013
  • Lexicomp®[database on the Internet]Hudson, OH, USALexicomp, Inc2013 Available from: http://webstore.lexi.com/Information/Product-Information/Lexi-Drugs-and-Lexi-Interact-DetailsAccessed February 12, 2013
  • Medscape Reference Online Drug Interaction Checker [database on the Internet]New York, NY, USAWebMD LLC2013 Available from: http://reference.medscape.com/drug-interactioncheckerAccessed February 13, 2013
  • Monthly Index of Medical Specialties (MIMS) Interaction Checker [database on the Internet]London, United KingdomUBM plc2013 Available from: http://www.mims.com/USA/interaction/AdvancedSearch/Accessed February 13, 2013
  • AbarcaJMaloneDCArmstrongEPConcordance of severity ratings provided in four drug interaction compendiaJ Am Pharm Assoc (2003)200444213614115098847
  • FuldaTRValuckRJZandenJVParkerSByrnsPJDisagreement among drug compendia on inclusion and ratings of drug–drug interactionsCurr Ther Res Clin Exp2000618540548
  • VitryAIComparative assessment of four drug interaction compendiaBr J Clin Pharmacol200763670971417166171
  • Federal Ministry of Health, NigeriaNational Guidelines for Paediatric HIV and AIDS Treatment and CareAbujaFederal Ministry of Health2007 Available from: http://www.who.int/hiv/amds/Nigeria_paediatric_2007.pdfAccessed November 30, 2012
  • Liverpool HIV Pharmacology Group [database on the Internet]Cheshire, United KingdomThe University of Liverpool and eMed- Fusion2010 Available from: http://www.hiv-druginteractions.orgAccessed December 1, 2012
  • ArmahizerMJKane-GillSLSmithburgerPLAnthesAMSeybertALComparing drug–drug interaction severity for clinician opinion to propriety databasesISRN Critical Care2013 Article ID 347346
  • TatroDSDrug interaction factsThe Authority on Drug InteractionsSt Louis, MOWolters Kluwer Health Facts and Comparisons2008
  • BaxterKPrestonCStockley’s Drug Interactions10th edLondonThe Pharmaceutical Press2013
  • Joint Formulary CommitteeBritish National Formulary61st edLondonBritish Medical Association and Royal Pharmaceutical Society of Great Britain2011
  • WongCMKoYChanAClinically significant drug–drug interactions between oral anticancer agents and non-anticancer agents: profiling and comparison of two drug compendiaAnn Pharmacother200842121737174819033481
  • ChaoSDMaibachHILack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugsAm J Clin Dermatol20056210511115799682
  • YiuPNguyenNNHolodniyMClinically significant drug interactions in younger and older human immunodeficiency virus-positive patients receiving antiretroviral therapyPharmacother2011315480489
  • MillerCDEl-KholiRFaragonJJLodiseTPPrevalence and risk factors for clinically significant drug interactions with antiretroviral therapyPharmacotherapy200727101379138617896893
  • MartinKBegaudBLatryPMiremont-SalameGFourrierAMooreNDifferences between clinical trials and postmarketing useBr J Clin Pharmacol2004571869214678345
  • PascualJDienerHCMassiouHValue of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an exampleJ Headache Pain200671273316440139
  • HazletTKLeeTAHanstenPDHornJRPerformance of community pharmacy drug interaction softwareJ Am Pharm Assoc (Wash)200141220020411297332
  • HanstenPDHornJRHazletTKORCA: OpeRational ClassificAtion of drug interactionsJ Am Pharm Assoc (Wash)200141216116511297327
  • HornJRHanstenPDChanLNProposal for a new tool to evaluate drug interaction casesAnn Pharmacother200741467468017389673

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.